The pact with NIPER "will promote academic excellence and research in the areas of pharmaceuticals and consumer healthcare products, to cater to the current and future needs of the pharmaceutical industry," Sanofi India said in a filing to BSE.
As per the pact, the company will provide opportunities of internship or project work to NIPER Kolkata MS/PhD students at manufacturing sites, ensure association of R&D heads with the dissertation work, provide career growth opportunities and undertake collaborative research activities in identified areas, it added.
Commenting on the development, Sanofi India MD Shailesh Ayyangar said: "The era of academia-industry collaboration to address the mammoth task of capacity building to meet our healthcare challenges has well and truly begun."
Shares of Sanofi India Ltd were today closed 0.39 per cent down at Rs 4,179.25 apiece on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
